Page 17 - Expert View News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vinod Karki, Equity Strategist at ICICI Securities, highlights market trends with a focus on domestic cyclicals, defensives, and FPI buying behavior. He anticipates a tapering down of earnings growth from a low base, emphasizing the importance of maintaining valuations in the market. Karki points out that DIIs and FIIs being an equal footing in terms of net buying is keeping our markets relatively expensive .

Kunj Bansal discusses the re-rating of public sector banks catching up with private banks, mixed retail sector performance, RBI directive benefiting banks, and the importance of fundamentals and valuation for higher returns in the investment.

Aditya Agarwala of Invest4edu discusses market insights including key levels for Nifty and Bank Nifty. He anticipates resistance at 50,000 on Bank Nifty and a potential new all-time high for Nifty around 23,000. Aurobindo Pharma is one of his picks. At current levels, one can initiate fresh long in the stock for a target of Rs 1,300 on the upside with a stop loss at Rs 1,120 on the downside. The second stock is Astral. This is one stock which has clearly bucked the trend and has been making higher highs and higher lows.

Suresh Narayanan of Nestle India points out that the operating margins are up by 270 basis points, net profits by 250 basis points and cash generation by over 41 billion, that is about 17% of sales. The core fundamentals of the organisation demonstrates resilient growth in core categories. He also talks about the company's commitment to reducing sugar content for sustainable long-term success.

CMD Pradip Kumar Das elaborates on IREDA's growth strategy, leveraging Navratna status for lower borrowing costs and overseas green bond exploration to support sustainable project financing and brand building efforts.